Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients

Translational Psychiatry

Volumn 4, Issue , 2014, Pages

  Wockner, L F ^a   Noble, E P ^b   Lawford, B R ^a,d   Young, R Mc D ^c   Morris, C P ^c   Whitehall, V L J ^a   Voisey, J ^c  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Brain; DNA methylation; Epigenetics; Schizophrenia

Indexed keywords

AKT1 PROTEIN; DNA METHYLTRANSFERASE 1; DYSBINDIN; NANOBEAD; NEURONAL NITRIC OXIDE SYNTHASE; PPP3CC PROTEIN; PROTEIN KINASE B; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG; PROTEIN; PROTEIN KINASE B 1;

ADULT; AGED; ARTICLE; AUTOPSY; BLOOD; BRAIN TISSUE; CAUSE OF DEATH; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MODIFICATION; ENVIRONMENTAL FACTOR; EPIGENETICS; FEMALE; FRONTAL CORTEX; GENE EXPRESSION REGULATION; GENE LOCATION; GENE PROBE; GENETIC ASSOCIATION; GENETIC RISK; HEREDITY; HUMAN; HUMAN TISSUE; ILLUMINATION; MALE; MICROCHIP ANALYSIS; MIDDLE AGED; PROGNOSIS; SCHIZOPHRENIA; GENE IDENTIFICATION; HUMAN GENOME; LEUKOCYTE; PROMOTER REGION; CLASSIFICATION; FRONTAL LOBE; GENETIC EPIGENESIS; GENETICS; METABOLISM;

AGED; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FRONTAL LOBE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 84893135952     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2013.111     Document Type: Article

References (47)

1. McGuffin P, Gottesman II. Risk factors for schizophrenia. N Engl J Med 1999; 341: 370-371.
2. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003; 60: 1187-1192.
3. Pedersen CB, Mortensen PB. Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Arch Gen Psychiatry 2001; 58: 1039-1046.
4. Cantor-Graae E, Selten JP. Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry 2005; 162: 12-24.
5. Arseneault L, Cannon M, Fisher HL, Polanczyk G, Moffitt TE, Caspi A. Childhood trauma and children's emerging psychotic symptoms: a genetically sensitive longitudinal cohort study. Am J Psychiatry 2011; 168: 65-72.
6. Brown AS, Derkits EJ. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 2010; 167: 261-280.
7. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319-328.
8. McGrath JJ, Burne TH, Feron F, Mackay-Sim A, Eyles DW. Developmental vitamin D deficiency and risk of schizophrenia: a 10-year update. Schizophr Bull 2010; 36: 1073-1078.
9. Rethelyi JM, Benkovits J, Bitter I. Genes and environments in schizophrenia: the different pieces of a manifold puzzle. Neurosci Biobehav Rev advance online publication, 26 April 2013; e-pub ahead of print. 10 Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007; 8: 253-262.
10. Nishioka M, Bundo M, Koike S, Takizawa R, Kakiuchi C, Araki T et al. Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia. J Hum Genet 2013; 58: 91-97.
11. Dempster EL, Pidsley R, Schalkwyk LC, Owens S, Georgiades A, Kane F et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet 2011; 20: 4786-4796.
12. Abdolmaleky HM, Cheng KH, Russo A, Smith CL, Faraone SV, Wilcox M et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005; 134B: 60-66.
13. Grayson DR, Jia X, Chen Y, Sharma RP, Mitchell CP, Guidotti A et al. Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci USA 2005; 102: 9341-9346.
14. Abdolmaleky HM, Cheng KH, Faraone SV, Wilcox M, Glatt SJ, Gao F et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet 2006; 15: 3132-3145.
15. Iwamoto K, Bundo M, Yamada K, Takao H, Iwayama-Shigeno Y, Yoshikawa T et al. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci 2005; 25: 5376-5381.
16. Abdolmaleky HM, Yaqubi S, Papageorgis P, Lambert AW, Ozturk S, Sivaraman V et al. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophr Res 2011; 129: 183-190.
17. Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 2008; 82: 696-711.
18. Kinoshita M, Numata S, Tajima A, Shimodera S, Ono S, Imamura A et al. DNA methylation signatures of peripheral leukocytes in schizophrenia. Neuromolecular Med 2013; 15: 95-101.
19. Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 2012; 13(6): R43.
20. Carrard A, Salzmann A, Malafosse A, Karege F. Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. J Affect Disord 2011; 132: 450-453.
21. Ghadirivasfi M, Nohesara S, Ahmadkhaniha HR, Eskandari MR, Mostafavi S, Thiagalingam S et al. Hypomethylation of the serotonin receptor type-2 A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2011; 156B: 536-545.
22. Kordi-Tamandani DM, Sahranavard R, Torkamanzehi A. DNA methylation and expression profiles of the brain-derived neurotrophic factor (BDNF) and dopamine transporter (DAT1) genes in patients with schizophrenia. Mol Biol Rep 2012; 39: 10889-10893.
23. Kordi-Tamandani DM, Dahmardeh N, Torkamanzehi A. Evaluation of hypermethylation and expression pattern of GMR2, GMR5, GMR8, and GRIA3 in patients with schizophrenia. Gene 2013; 515: 163-166.
24. Melas PA, Rogdaki M, Osby U, Schalling M, Lavebratt C, Ekstrom TJ. Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset. FASEB J 2012; 26: 2712-2718.
25. Nohesara S, Ghadirivasfi M, Mostafavi S, Eskandari MR, Ahmadkhaniha H, Thiagalingam S et al. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J Psychiatr Res 2011; 45: 1432-1438.
26. Hansen KD, Aryee M. minfi: Analyze Illumina's 450k methylation arrays. R package version 1.4.0 http://www.bioconductor.org; 2012
27. Maksimovic J, Gordon L, Oshlack A. SWAN: subset-quantile within array normalization for Illumina Infinium HumanMethylation450 BeadChips. Genome Biol 2012; 13: R44.
28. Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L et al. Comparison of betavalue and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 2010; 11: 587.
29. Smyth GK. Limma: linear models for microarray data. In: Bioinformatics and Computational Biology Solutions Using R and Bioconductor, R. 2005; 397-420.
30. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: 1.
31. Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000; 57: 1061-1069.
32. Huang HS, Matevossian A, Jiang Y, Akbarian S. Chromatin immunoprecipitation in postmortem brain. J Neurosci Methods 2006; 156: 284-292.
33. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological) 1995; 57: 289-300.
34. Houseman EA, RPMM: Recursively Partitioned Mixture Model. R package version 1.10. http://CRAN.R-project.org/package = RPMM; 2012.
35. Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 2012; 22: 271-282.
36. Nishioka M, Bundo M, Kasai K, Iwamoto K. DNA methylation in schizophrenia: progress and challenges of epigenetic studies. Genome Med 2012; 4: 96.
37. Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlen SE, Greco D et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 2012; 7: e41361.
38. Lawford BR, Young RM, Swagell CD, Barnes M, Burton SC, Ward WK et al. The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia. Schizophr Res 2005; 73: 31-37.
39. Voisey J, Swagell CD, Hughes IP, Lawford BR, Young RM, Morris CP. Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia. Eur Psychiatry 2010; 25: 314-319.
40. Voisey J, Swagell CD, Hughes IP, Lawford BR, Young RM, Morris CP. A novel DRD2 single-nucleotide polymorphism associated with schizophrenia predicts age of onset: HapMap tag-single-nucleotide polymorphism analysis. Genet Test Mol Biomarkers 2011; 16: 77-81.
41. Voisey J, Swagell CD, Hughes IP, Lawford BR, Young RM, Morris CP. HapMap tag- SNP analysis confirms a role for COMT in schizophrenia risk and reveals a novel association. Eur Psychiatry 2012; 27: 372-376.
42. Numata S, Ye T, Hyde TM, Guitart-Navarro X, Tao R, Wininger M et al. DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet 2012; 90: 260-272.
43. Chen ML, Wu S, Tsai TC, Wang LK, Tsai FM. Regulation of macrophage immune responses by antipsychotic drugs. Immunopharmacol Immunotoxicol 2013; 35: 573-580.
44. Iwamoto K, Bundo M, Ueda J, Oldham MC, Ukai W, Hashimoto E et al. Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons. Genome Res 2011; 21: 688-696.
45. Kuhn A, Kumar A, Beilina A, Dillman A, Cookson MR, Singleton AB. Cell populationspecific expression analysis of human cerebellum. BMC Genomics 2012; 13: 610.
46. Montano CM, Irizarry RA, Kaufmann WE, Talbot K, Gur RE, Feinberg AP et al. Measuring cell-type specific differential methylation in human brain tissue. Genome Biol 2013; 14: R94.
47. Bhutani N, Burns DM, Blau HM. DNA demethylation dynamics. Cell 2011; 146: 866-872.